Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Y Zuo, SK Estes, RA Ali, AA Gandhi… - Science translational …, 2020 - science.org
Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung
histopathology often reveals fibrin-based blockages in the small blood vessels of patients …

[HTML][HTML] Neutrophil extracellular traps and thrombosis in COVID-19

Y Zuo, M Zuo, S Yalavarthi, K Gockman… - Journal of Thrombosis …, 2021 - Springer
Studies of patients with COVID-19 have demonstrated markedly dysregulated coagulation
and a high risk of morbid arterial and venous thrombotic events. Elevated levels of blood …

[HTML][HTML] Neutrophil extracellular traps in COVID-19

Y Zuo, S Yalavarthi, H Shi, K Gockman, M Zuo… - JCI insight, 2020 - ncbi.nlm.nih.gov
In severe cases of coronavirus disease 2019 (COVID-19), viral pneumonia progresses to
respiratory failure. Neutrophil extracellular traps (NETs) are extracellular webs of chromatin, …

[HTML][HTML] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Y Zuo, M Warnock, A Harbaugh, S Yalavarthi… - Scientific reports, 2021 - nature.com
Patients with coronavirus disease-19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. However, bleeding complications have also been observed in some …

Neutrophil calprotectin identifies severe pulmonary disease in COVID-19

…, Y Zuo, S Yalavarthi, K Gockman, M Zuo… - Journal of Leucocyte …, 2021 - academic.oup.com
Severe cases of coronavirus disease 2019 (COVID-19) are regularly complicated by
respiratory failure. Although it has been suggested that elevated levels of blood neutrophils …

[HTML][HTML] Autoantibodies stabilize neutrophil extracellular traps in COVID-19

Y Zuo, S Yalavarthi, SA Navaz, CK Hoy, A Harbaugh… - JCI insight, 2021 - ncbi.nlm.nih.gov
The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is
recognized to play an important role in the thromboinflammatory milieu inherent to severe …

Prothrombotic antiphospholipid antibodies in COVID-19

Y Zuo, SK Estes, RA Ali, AA Gandhi, S Yalavarthi, H Shi… - MedRxiv, 2020 - medrxiv.org
Patients with coronavirus disease 19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. At the same time, lung histopathology often reveals fibrin-based …

[HTML][HTML] Endothelial cell–activating antibodies in COVID‐19

H Shi, Y Zuo, S Navaz, A Harbaugh… - Arthritis & …, 2022 - Wiley Online Library
Objective While endothelial dysfunction has been implicated in the widespread thromboinflammatory
complications of COVID‐19, the upstream mediators of endotheliopathy remain, for …

[PDF][PDF] Neutrophil extracellular traps (NETs) and thrombosis in COVID-19

Y Zuo, M Zuo, S Yalavarthi, K Gockman, JA Madison… - regenhealthsolutions.info
Here, we report on five patients whose hospitalizations for COVID-19 were complicated by
venous thromboembolism (VTE). All demonstrated high levels of D-dimer as well as high …

[HTML][HTML] Prothrombotic autoantibodies in serum from hospitalized patients with COVID-19

Y Zuo, SK Estes, RA Ali, AA Gandhi… - Science translational …, 2020 - ncbi.nlm.nih.gov
Patients with coronavirus disease 19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. Lung histopathology often reveals fibrin-based occlusions in the small …